BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31207142)

  • 41. Hereditary Diffuse Infiltrating Retinoblastoma.
    Schedler KJ; Traine PG; Lohmann DR; Haritoglou C; Metz KA; Rodrigues EB
    Ophthalmic Genet; 2016; 37(1):95-7. PubMed ID: 24892564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between Family
    Zhang Y; Wang Y; Huang D; Ma J; Zhang W; Gu H; Zhou Y; Yi Y; Zhang P
    Dis Markers; 2021; 2021():9981028. PubMed ID: 34336010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spectrum of RB1 mutations identified in 403 retinoblastoma patients.
    Price EA; Price K; Kolkiewicz K; Hack S; Reddy MA; Hungerford JL; Kingston JE; Onadim Z
    J Med Genet; 2014 Mar; 51(3):208-14. PubMed ID: 24225018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
    Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
    Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications.
    Gregersen PA; Urbak SF; Funding M; Overgaard J; Jensen UB; Alsner J
    Acta Oncol; 2016; 55(4):412-7. PubMed ID: 26494512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic).
    Reddy MA; Butt M; Hinds AM; Duncan C; Price EA; Sagoo MS; Onadim Z
    Ophthalmol Retina; 2021 Apr; 5(4):381-387. PubMed ID: 32835838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [From gene to disease; retinoblastoma and the RB1 gene].
    Scheffer H; Imhof SM; Moll AC
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1245-7. PubMed ID: 11455690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Promoting regulated gene diagnosis for retinoblastoma in clinical work].
    Liang JH; Zhu XM
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):806-810. PubMed ID: 31715676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma.
    Fukushima H; Suzuki R; Hiraoka T; Suzuki S; Noguchi E; Takada H
    Jpn J Clin Oncol; 2023 Aug; 53(9):863-865. PubMed ID: 37345682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma.
    Erdoğan ÖŞ; Ödemiş DA; Kayım ZY; Gürbüz O; Tunçer ŞB; Kılıç S; Çelik B; Tuncer S; Bay SB; Kebudi R; Yazıcı H
    Pathol Res Pract; 2024 Jan; 253():154939. PubMed ID: 38006838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
    Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-grade glioma: A rare second tumor in retinoblastoma survivors.
    Dalvi N; Kleinerman RA; Epelman S; Abramson DH; Dunkel IJ
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28770. PubMed ID: 33063942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ROUTINE FUNDUS SCREENING OF FAMILIES OF CHILDREN WITH RETINOBLASTOMA: A Prospective Study of 131 Consecutive Families.
    Kaliki S; Gupta Rathi S; Patel A
    Retina; 2019 Jul; 39(7):1326-1332. PubMed ID: 29470311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uncommon RB1 somatic mutations in a unilateral retinoblastoma patient.
    Ottaviani D; Alonso C; Szijan I
    Medicina (B Aires); 2015; 75(3):137-41. PubMed ID: 26117602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel RB1 germline mutation in a healthy man.
    Ramos-Dávila EM; Garza-Garza LA; Villafuerte-de la Cruz R; Aguilar-Y-Mendez D; Morales-Garza HJ; Garza-Leon M; Ruiz-Lozano RE; Ancona-Lezama D
    Ophthalmic Genet; 2022 Aug; 43(4):561-566. PubMed ID: 35410579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of predisposing epimutation in retinoblastoma.
    Gelli E; Pinto AM; Somma S; Imperatore V; Cannone MG; Hadjistilianou T; De Francesco S; Galimberti D; Currò A; Bruttini M; Mari F; Renieri A; Ariani F
    Hum Mutat; 2019 Feb; 40(2):201-206. PubMed ID: 30427563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma.
    Parsam VL; Kannabiran C; Honavar S; Vemuganti GK; Ali MJ
    J Genet; 2009 Dec; 88(4):517-27. PubMed ID: 20090211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A possible hot spot in exon 21 of the retinoblastoma gene predisposing to a low penetrant retinoblastoma phenotype?
    Ahmad NN; Melo MB; Singh AD; Donoso LA; Shields JA
    Ophthalmic Genet; 1999 Dec; 20(4):225-31. PubMed ID: 10617920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.